MIGLITOL+METFORMIN
About MIGLITOL+METFORMIN
MIGLITOL+METFORMIN belongs to the class of medications called ‘antidiabetic drugs’ used to treat type 2 diabetes mellitus. Type 2 diabetes mellitus is a chronic or life-long condition in which blood sugar or glucose levels rise more than normal. It occurs when the body does not produce enough insulin (utilizes glucose to produce energy) or if produced, it cannot function properly in the body.
MIGLITOL+METFORMIN contains Miglitol and Metformin. Metformin acts by decreasing liver glucose production and intestinal glucose uptake. Miglitol works by inhibiting intestinal enzymes that break complex sugars into simple sugars like glucose. Together, MIGLITOL+METFORMIN can effectively prevent the rise in glucose levels in the body.
You should take this medicine exactly as prescribed by the doctor. The common side-effects of MIGLITOL+METFORMIN are flatulence (gas), diarrhoea, abdominal pain, feeling sick (nausea), being sick (vomiting) and loss of appetite. These side effects can be reduced if this medicine is taken with food or after a meal. However, if any of these side effects persist or get worse, inform your doctor immediately.
It is not recommended to take MIGLITOL+METFORMIN if you are allergic to any contents of it. MIGLITOL+METFORMIN is not recommended if you are having any intestinal problems such as inflammation, ulcers, blockage, hernia, liver problems, severe kidney impairment, uncontrolled diabetes, severe dehydration, severe infections, and a recent history of heart attack or heart failure. MIGLITOL+METFORMIN is not recommended for children and adolescents below 18 years, pregnant women, and breastfeeding mothers. It should be used with caution in elderly people as they may require dose adjustments. MIGLITOL+METFORMIN may interact with alcohol and worsen the condition. MIGLITOL+METFORMIN may cause hypoglycemia (low glucose levels), so avoid driving if you develop weakness, dizziness, fast heartbeat, or decrease in alertness.
Uses of MIGLITOL+METFORMIN
Medicinal Benefits
MIGLITOL+METFORMIN is a combination of two drugs: Miglitol and Metformin. This combination therapy is preferred in patients with poorly controlled diabetes. It reduces blood glucose levels, especially post-prandial glucose levels (glucose levels after meals) in type 2 diabetes mellitus patients. An increase in post-prandial glucose levels can be a risk factor for diabetes complications such as tissue and organ damage. So, a decrease in glucose levels helps control diabetes, reduce this risk and improve healthy life.
Directions for Use
Storage
Side Effects of MIGLITOL+METFORMIN
- Flatulence (gas)
- Diarrhoea
- Abdominal pain
- Feeling sick (nausea)
- Being sick (vomiting)
- Loss of appetite
Patients Concern
Disease/Condition Glossary
Type 2 Diabetes Mellitus: It is a chronic or lifelong disease that keeps the body away from properly utilizing insulin. Hence, people affected with type 2 diabetes either do not produce enough insulin or are resistant to insulin. Middle-aged or older are most likely to suffer from type 2 diabetes, which is also known as adult-onset diabetes. Type 2 diabetes symptoms include increased thirst, frequent urination at night, slow wound healing, increased hunger, fatigue and blurred vision. In some cases, there may be weight gain while in rare cases weight loss may be observed. The complication of type 2 diabetes also include neuropathy (nerve problems), nephropathy (kidney problems) and retinopathy (damaged retina of eyes or blindness), loss of limbs, sexual dysfunction and increase chance of heart attack or stroke.
FAQs
MIGLITOL+METFORMIN is used in the treatment of type 2 diabetes mellitus. It contains Miglitol and Metformin. Metformin acts by decreasing liver glucose production and intestinal glucose uptake. Miglitol works by inhibiting intestinal enzymes that break complex sugars into simple sugars like glucose. Together, MIGLITOL+METFORMIN can effectively prevent the rise in glucose levels in the body.
MIGLITOL+METFORMIN can be taken on an empty stomach. However, it is advised to take with food or after meals to reduce the bowel side-effects and increase its efficiency.
Inform your doctor before having an X-ray or CT scan that you are taking MIGLITOL+METFORMIN. Some imaging scans may involve the use of the injection of contrast materials that contain iodine. Concomitant use of this injection with MIGLITOL+METFORMIN may affect your kidney function. So, the doctor may advise you to stop MIGLITOL+METFORMIN before the examination and will decide when to restart it.
MIGLITOL+METFORMIN may cause hypoglycemia (low blood sugar level) characterized by sweating, dizziness, palpitations, shivering, confusion, irritability, etc. If you experience these symptoms, try to eat candies or glucose biscuits. If your condition doesn't improve, consult your doctor immediately.
MIGLITOL+METFORMIN is recommended for the treatment of type 2 diabetes and not used for treating type 1 diabetes, a condition which occurs mainly due to deficiency of insulin.
